Variant report

Variant	nsv537708
Chromosome Location	chr5:28165763-28370968
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:605)
CpG islands
(count:61)
Chromatin interactive
region (count:15)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:605 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:28345040-28345171	HepG2	liver:	n/a	n/a
2	ATF1	chr5:28256860-28256921	K562	blood:	n/a	n/a
3	BACH1	chr5:28187505-28187822	H1-hESC	embryonic stem cell:	n/a	n/a
4	BATF	chr5:28213539-28213888	GM12878	blood:	n/a	chr5:28213739-28213750
5	BATF	chr5:28213553-28213902	GM12878	blood:	n/a	chr5:28213739-28213750
6	BCL11A	chr5:28217210-28217480	GM12878	blood:	n/a	n/a
7	BCL11A	chr5:28217233-28217496	GM12878	blood:	n/a	n/a
8	BCL3	chr5:28313337-28314572	A549	lung:	n/a	n/a
9	BHLHE40	chr5:28217243-28217471	GM12878	blood:	n/a	n/a
10	BHLHE40	chr5:28234867-28234878	GM12878	blood:	n/a	n/a
11	BRCA1	chr5:28234631-28234632	GM12878	blood:	n/a	n/a
12	BRCA1	chr5:28313569-28314508	Hela-S3	cervix:	n/a	n/a
13	BRCA1	chr5:28301710-28302170	Hela-S3	cervix:	n/a	n/a
14	BRCA1	chr5:28190095-28190272	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr5:28339791-28340075	A549	lung:	n/a	n/a
16	CEBPB	chr5:28209552-28209914	HepG2	liver:	n/a	chr5:28209729-28209740
17	CEBPB	chr5:28276810-28277016	HepG2	liver:	n/a	chr5:28276907-28276916 chr5:28276905-28276916
18	CEBPB	chr5:28313387-28314730	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr5:28218733-28219051	Hela-S3	cervix:	n/a	chr5:28218888-28218899
20	CEBPB	chr5:28324952-28325132	H1-hESC	embryonic stem cell:	n/a	n/a
21	CEBPB	chr5:28341331-28341513	A549	lung:	n/a	n/a
22	CEBPB	chr5:28299872-28300104	HepG2	liver:	n/a	chr5:28299968-28299977 chr5:28299967-28299978 chr5:28299966-28299979
23	CEBPB	chr5:28299854-28300035	A549	lung:	n/a	chr5:28299968-28299977 chr5:28299967-28299978 chr5:28299966-28299979
24	CEBPB	chr5:28209615-28209859	K562	blood:	n/a	chr5:28209729-28209740
25	CEBPB	chr5:28292764-28293045	HepG2	liver:	n/a	chr5:28292879-28292890
26	CEBPB	chr5:28215303-28215727	MCF-7	breast:	n/a	chr5:28215570-28215581
27	CEBPB	chr5:28194833-28195179	HepG2	liver:	n/a	chr5:28194982-28194993
28	CEBPB	chr5:28301428-28302319	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr5:28194915-28195172	A549	lung:	n/a	chr5:28194982-28194993
30	CEBPB	chr5:28190131-28190367	A549	lung:	n/a	chr5:28190293-28190304 chr5:28190293-28190304
31	CEBPB	chr5:28218749-28219007	A549	lung:	n/a	chr5:28218888-28218899
32	CEBPB	chr5:28313429-28314428	A549	lung:	n/a	n/a
33	CEBPB	chr5:28215280-28215719	MCF-7	breast:	n/a	chr5:28215570-28215581
34	CEBPB	chr5:28218715-28219038	HepG2	liver:	n/a	chr5:28218888-28218899
35	CEBPB	chr5:28313448-28314424	A549	lung:	n/a	n/a
36	CEBPB	chr5:28176926-28177004	H1-hESC	embryonic stem cell:	n/a	n/a
37	CEBPB	chr5:28281482-28281746	A549	lung:	n/a	n/a
38	CEBPB	chr5:28305998-28306364	Hela-S3	cervix:	n/a	n/a
39	CEBPB	chr5:28218772-28219073	IMR90	lung:	n/a	chr5:28218888-28218899
40	CEBPB	chr5:28209564-28209904	IMR90	lung:	n/a	chr5:28209729-28209740
41	CEBPB	chr5:28313318-28314557	A549	lung:	n/a	n/a
42	CEBPB	chr5:28218748-28219015	K562	blood:	n/a	chr5:28218888-28218899
43	CEBPB	chr5:28209689-28209881	H1-hESC	embryonic stem cell:	n/a	chr5:28209729-28209740
44	CEBPB	chr5:28209551-28209899	A549	lung:	n/a	chr5:28209729-28209740
45	CEBPB	chr5:28222230-28222533	HepG2	liver:	n/a	chr5:28222361-28222372
46	CEBPB	chr5:28281410-28281635	HepG2	liver:	n/a	n/a
47	CEBPB	chr5:28202427-28202699	Hela-S3	cervix:	n/a	n/a
48	CHD2	chr5:28301646-28302209	Hela-S3	cervix:	n/a	n/a
49	CHD2	chr5:28266120-28266234	H1-hESC	embryonic stem cell:	n/a	n/a
50	CHD2	chr5:28313721-28314682	Hela-S3	cervix:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:28287516-28287566	AG04449	skin:	fetal
2	chr5:28287516-28287566	ECC-1	luminal epithelium:	n/a
3	chr5:28287516-28287566	RPTEC	kidney:	n/a
4	chr5:28287516-28287566	IMR90	lung:	fetal
5	chr5:28287516-28287566	HepG2	liver:	n/a
6	chr5:28287516-28287566	HRCEpiC	kidney:	n/a
7	chr5:28287516-28287566	HCM	heart:	n/a
8	chr5:28287516-28287566	GM12878	blood:	n/a
9	chr5:28287516-28287566	CMK	blood:	n/a
10	chr5:28287516-28287566	HCT-116	colon:	n/a
11	chr5:28287516-28287566	SK-N-MC	brain:	n/a
12	chr5:28287516-28287566	HRPEpiC	eye:	n/a
13	chr5:28287516-28287566	U87	brain:	n/a
14	chr5:28287516-28287566	H1-hESC	embryonic stem cell:	embryo
15	chr5:28287516-28287566	HUVEC	blood vessel:	n/a
16	chr5:28287516-28287566	HCPEpiC	choroid plexus:	n/a
17	chr5:28287516-28287566	SK-N-SH	brain:	n/a
18	chr5:28287516-28287566	HAEpiC	amniotic membrane:	n/a
19	chr5:28287516-28287566	PANC-1	pancreas:	n/a
20	chr5:28287516-28287566	NB4	blood:	n/a
21	chr5:28287516-28287566	K562	blood:	n/a
22	chr5:28287516-28287566	NH-A	brain:	n/a
23	chr5:28287516-28287566	HPAEpiC	pulmonary alveolar:	n/a
24	chr5:28287516-28287566	GM06990	blood:	n/a
25	chr5:28287516-28287566	ProgFib	skin:	n/a
26	chr5:28287516-28287566	HL-60	blood:	n/a
27	chr5:28287516-28287566	BJ	skin:	n/a
28	chr5:28287516-28287566	SKMC	muscle:	n/a
29	chr5:28287516-28287566	NT2-D1	testis:	n/a
30	chr5:28287516-28287566	PFSK-1	brain:	n/a
31	chr5:28287516-28287566	AG10803	skin:	n/a
32	chr5:28287516-28287566	AoSMC	blood vessel:	n/a
33	chr5:28287516-28287566	A549	lung:	n/a
34	chr5:28287516-28287566	AG04450	lung:	fetal
35	chr5:28287516-28287566	GM12891	blood:	n/a
36	chr5:28287516-28287566	NHDF-neo	bronchial:	n/a
37	chr5:28287516-28287566	GM12892	blood:	n/a
38	chr5:28287516-28287566	HIPEpiC	eye:	n/a
39	chr5:28287516-28287566	AG09319	gingival:	n/a
40	chr5:28287516-28287566	Hela-S3	cervix:	n/a
41	chr5:28287516-28287566	GM19239	blood:	n/a
42	chr5:28287516-28287566	Jurkat	blood:	n/a
43	chr5:28287516-28287566	BE2_C	brain:	n/a
44	chr5:28287516-28287566	ovcar-3	ovarian:	n/a
45	chr5:28287516-28287566	PrEC	prostate:	n/a
46	chr5:28287516-28287566	LNCaP	prostate:	n/a
47	chr5:28287516-28287566	HCF	heart:	n/a
48	chr5:28287516-28287566	HMEC	breast:	n/a
49	chr5:28287516-28287566	Hepatocyte	liver:	n/a
50	chr5:28287516-28287566	Caco-2	colon:	n/a

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:28356315..28359101-chr5:28359842..28361438,2	MCF-7	breast:
2	chr10:75910908..75911610-chr5:28346421..28347009,2	HCT-116	colon:
3	chr10:58351002..58353905-chr5:28242920..28245430,2	MCF-7	breast:
4	chr5:28344669..28345343-chr5:28766345..28767141,3	MCF-7	breast:
5	chr5:28173448..28176167-chr5:28180789..28182716,2	K562	blood:
6	chr5:28344204..28345499-chr5:28766065..28767256,3	MCF-7	breast:
7	chr5:28173448..28176167-chr5:28180789..28182716,2	K562	blood:
8	chr5:28344853..28345525-chr5:28576087..28576818,2	MCF-7	breast:
9	chr5:28344802..28345403-chr5:28575923..28576762,2	MCF-7	breast:
10	chr5:28213194..28214718-chr5:28216358..28217963,2	MCF-7	breast:
11	chr5:28212902..28214743-chr5:28218747..28220694,2	K562	blood:
12	chr5:28356315..28359101-chr5:28359842..28361438,2	MCF-7	breast:
13	chr5:28367693..28370424-chr5:28378574..28381486,2	MCF-7	breast:
14	chr5:28234903..28236719-chr5:28238534..28240532,2	K562	blood:
15	chr5:28234903..28236719-chr5:28238534..28240532,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CDH9-10	chr5:28213466-28214666	NONHSAT100812
2	lnc-CDH9-5	chr5:28286496-28286993	XLOC_004762
3	lnc-CDH9-5	chr5:28287748-28287772	XLOC_004762

No data

Variant related genes	Relation type
ENSG00000249785	TF binding region
ENSG00000250079	TF binding region
ENSG00000249785	CpG island
ENSG00000250079	CpG island
ENSG00000250079	chromatin interactions
ENSG00000156110	chromatin interactions
PITPNB	miRNA target sites
PITPNC1	miRNA target sites

Extended variants
information (count: 1477 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:1477 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564901434	chr5:28165778-28165779	Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs189810986	chr5:28165807-28165808	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs183129198	chr5:28165808-28165809	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs547351206	chr5:28165864-28165865	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs78392094	chr5:28165875-28165876	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs536111868	chr5:28165944-28165945	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs144237056	chr5:28166004-28166005	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs569471262	chr5:28166006-28166007	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs537951139	chr5:28166023-28166024	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs556427959	chr5:28166039-28166040	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs578042971	chr5:28166049-28166050	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs571841553	chr5:28166078-28166079	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs538693104	chr5:28166094-28166095	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs554115023	chr5:28166120-28166121	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs148710625	chr5:28166134-28166135	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs142465926	chr5:28166138-28166139	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs555214125	chr5:28166161-28166162	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs551338725	chr5:28166178-28166179	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs200815095	chr5:28166188-28166189	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs542182800	chr5:28166226-28166227	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs543984150	chr5:28166238-28166239	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs564863287	chr5:28166241-28166242	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs561972688	chr5:28166247-28166248	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs148706461	chr5:28166280-28166281	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs150914247	chr5:28166297-28166298	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs540689640	chr5:28166355-28166356	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs558887540	chr5:28166378-28166379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs529948131	chr5:28166383-28166384	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs548033951	chr5:28166390-28166391	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs57077934	chr5:28166392-28166393	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs111805947	chr5:28166396-28166397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs552334306	chr5:28166427-28166428	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs535765049	chr5:28166452-28166453	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs75404569	chr5:28166509-28166510	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs575522324	chr5:28166526-28166527	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs68055094	chr5:28166527-28166528	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs539095641	chr5:28166532-28166533	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs397743137	chr5:28166538-28166539	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs74474137	chr5:28166539-28166540	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs553897371	chr5:28166572-28166573	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs187801081	chr5:28166632-28166633	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs34437835	chr5:28166664-28166665	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs144452541	chr5:28166673-28166674	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs555351183	chr5:28166675-28166676	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs146603935	chr5:28166706-28166707	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs563581208	chr5:28166707-28166708	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs532309037	chr5:28166713-28166714	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs559077677	chr5:28166719-28166720	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs35676372	chr5:28166731-28166732	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs576877735	chr5:28166734-28166735	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Non-small cell lung cancer	20864512	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Cancer	16751803	CNVD
Breast cancer	16608533	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Lung cancer	16740712	CNVD
Renal cell carcinoma	18194544	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Non-small cell lung cancer	19010865	CNVD
Glioblastoma multiforme	22286061	CNVD
Compulsive disorder	18923513	CNVD
Epilepsy	18923513	CNVD
Prader-willi syndrome	18923513	CNVD
small cell lung cancer	20016488	CNVD
Ovarian cancer	21720365	CNVD
Lung cancer	18438408	CNVD
Glioma	20126413	CNVD
Non-small cell lung cancer	21829676	CNVD
Breast cancer	22032731	CNVD
Esophageal cancer	20955586	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:107 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:28164400-28166200	Enhancers	HUVEC	blood vessel
2	chr5:28164800-28166000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr5:28164800-28166000	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr5:28164800-28166000	Enhancers	Brain Substantia Nigra	brain
5	chr5:28164800-28166200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
6	chr5:28165200-28166000	Enhancers	Cortex derived primary cultured neurospheres	brain
7	chr5:28165400-28165800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr5:28165400-28165800	Active TSS	Brain Cingulate Gyrus	brain
9	chr5:28165400-28165800	Flanking Active TSS	Brain Hippocampus Middle	brain
10	chr5:28165400-28166200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr5:28165400-28166200	Enhancers	Ovary	ovary
12	chr5:28165600-28165800	Enhancers	Adipose Nuclei	Adipose
13	chr5:28165600-28166200	Enhancers	Placenta Amnion	Placenta Amnion
14	chr5:28165800-28166000	Enhancers	Brain Anterior Caudate	brain
15	chr5:28165800-28166800	Enhancers	Brain Hippocampus Middle	brain
16	chr5:28166000-28166400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
17	chr5:28166200-28166600	Weak transcription	HUVEC	blood vessel
18	chr5:28166400-28167400	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr5:28166800-28167000	Enhancers	HUVEC	blood vessel
20	chr5:28166800-28168800	Weak transcription	Brain Hippocampus Middle	brain
21	chr5:28168800-28169000	Enhancers	Brain Hippocampus Middle	brain
22	chr5:28177600-28177800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
23	chr5:28189600-28190200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr5:28189600-28190400	Enhancers	iPS-15b Cell Line	embryonic stem cell
25	chr5:28189600-28190400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
26	chr5:28189600-28190600	Enhancers	Breast Myoepithelial Primary Cells	Breast
27	chr5:28192600-28192800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
28	chr5:28192600-28192800	Enhancers	Brain Anterior Caudate	brain
29	chr5:28192600-28193400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
30	chr5:28192800-28193200	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
31	chr5:28192800-28193200	Active TSS	Brain Anterior Caudate	brain
32	chr5:28193000-28193400	Enhancers	Cortex derived primary cultured neurospheres	brain
33	chr5:28193200-28193400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr5:28202800-28203000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
35	chr5:28213800-28216800	Enhancers	Dnd41	blood
36	chr5:28215600-28216000	Enhancers	Fetal Kidney	kidney
37	chr5:28216800-28217600	Enhancers	Primary hematopoietic stem cells short term culture	blood
38	chr5:28216800-28217600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr5:28216800-28218000	Flanking Active TSS	Dnd41	blood
40	chr5:28216800-28218200	Enhancers	GM12878-XiMat	blood
41	chr5:28217000-28217600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr5:28218000-28218400	Enhancers	Dnd41	blood
43	chr5:28228400-28228800	Enhancers	Dnd41	blood
44	chr5:28234400-28234800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr5:28242800-28243400	Enhancers	Dnd41	blood
46	chr5:28243400-28245400	Weak transcription	Dnd41	blood
47	chr5:28245400-28247000	Enhancers	Dnd41	blood
48	chr5:28250000-28251200	Enhancers	Pancreatic Islets	Pancreatic Islet
49	chr5:28253200-28253800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
50	chr5:28255000-28255400	Enhancers	NH-A	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links